Medications

India rejects Bayer plea against cheap cancer drug (Update)

India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting inexpensive ...

Other

Pharma lobby blasts 'stupid' pandemic patent plans

Stripping patent protection from COVID-19 treatments is a "mind-bogglingly stupid" idea, the head of a leading pharmaceutical lobby said Wednesday, warning that the move would put industry innovation at risk.

Diseases, Conditions, Syndromes

New long-term antimicrobial catheter developed

A novel antimicrobial catheter that remains infection-free for up to twelve weeks could dramatically improve the lives of long-term catheter users. The scientists who have developed the new technology are presenting their ...

Diseases, Conditions, Syndromes

A COVID-19 vaccine strategy to give the body 'border protection'

A simple addition to injected COVID-19 vaccines could enhance their effectiveness and provide "border protection" immunity in areas like the nose and mouth to supplement antibodies in the bloodstream, new research suggests.

Diseases, Conditions, Syndromes

Chinese scientists ask for patent on US drug to fight virus

Scientists in the city at the center of China's virus outbreak have applied to patent a drug made by U.S. company Gilead Sciences Inc. to treat the disease, possibly fueling conflict over technology policy that helped trigger ...

page 11 from 26